Emmaus Life Sciences, Inc. (EMMA)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$12.5M$16.7M$29.6M$18.4M$20.6M$23.2M$22.8M$1.3M$128,500
Gross profit$11.6M$15.5M$28.3M$15.8M$17.3M$20.9M$21.7M$488,100$75,000
Research & development$313,000$657,000$1.2M$1.7M$4.1M$2.4M$2.2M
Operating expenses$11.4M$17.3M$24.7M$22.4M$23.4M$21.0M$26.2M$10.7M$7.2M$3.9M$2.7M$4.0M$4.3M$4.9M$5.4M$7.1M
Operating income$231,000−$1.9M$3.5M−$6.6M−$6.1M−$32,000−$4.5M−$10.2M−$7.1M−$3.8M−$2.6M−$3.8M−$4.2M−$4.8M−$5.3M−$6.5M
EBITDAderived$270,000−$1.9M$3.6M−$6.5M−$6.1M$28,000−$4.4M−$10.1M−$7.1M−$3.8M−$2.6M−$3.8M
Net income−$7.5M−$6.5M−$3.7M−$10.6M−$15.9M$1.4M−$54.8M−$9.6M−$7.1M−$5.9M−$3.4M−$2.7M−$10.9M−$3.4M−$8.9M−$8.2M
Basic EPSper diluted share-$0.12-$0.10-$0.07-$0.21-$0.32$30.00-$1.30-$1.86-$2.52-$9.26-$6.64-$0.03-$0.14-$1.81-$4.74-$0.16
Diluted EPSper diluted share-$0.12-$0.10-$0.07-$0.21-$0.32$30.00-$1.30-$1.86-$2.52-$9.26-$6.64-$0.03-$0.14-$1.81-$4.74-$0.16

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys1$800.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
1 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Sep 16, 2024Form 4Lim Seah H.DirectorBuyCommon stock, $0.001 par value20.0K$0.04$800.004.61M